Fingerprint
Dive into the research topics of 'A phase i study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase i study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma
Paul Monk, Elaine Lam, Amir Mortazavi, Kari Kendra, Gregory B. Lesinski, Thomas A. Mace, Susan Geyer, William E. Carson, Sanaa Tahiri, Arvinder Bhinder, Steven K. Clinton, Thomas Olencki
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations